#dea

#dea

The Trump administration is set to weigh in on whether the hallucinogenic compound psilocybin should be moved into a less restrictive class of drugs under federal regulations. Regulation of psilocybin - the "magic" substance in psychedelic mushrooms - has been a hot-button issue for Californians in recent years, but repeated attempts by state lawmakers to allow medical use of the substance have floundered. Now it seems change may come at the federal level. The U.S. Department of Health and Human Services is weighing a petition sent earlier this month by the Drug Enforcement Administration to review the scientific evidence and consider easing restrictions.

Donald Trump's art of negotiation relies heavily on the art of pushing his counterparts Mexico in this case to the limit. Just when, according to President Claudia Sheinbaum, it seemed that the relationship between the two nations was based on respect among equals and non-subordination, Trump launched a new challenge this week to pressure Mexico and extract even more security benefits from Washington's main trading partner.

President Claudia Sheinbaum stated there is no agreement with the DEA regarding the Project Portero operation. This was in response to a DEA announcement about collaboration against drug cartels.

Based on your time as a DEA agent in the field, particularly in Mexico, these tattoos are consistent with MS-13 associations? Yes, sir, that's correct.